DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE

Aim. In patients with chronic heart failure (CHF) of ischemic aetiology, to assess the dynamics of heart rate variability (HRV) and ventricular ectopic activity during the complex, ivabradine-including therapy. Material and methods. In total, 90 patients with CHF and stable angina pectoris were exam...

Full description

Bibliographic Details
Main Authors: M. V. Surovtseva, N. A. Koziolova, A. I. Chernyavina
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2012-12-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1305
_version_ 1797857117732864000
author M. V. Surovtseva
N. A. Koziolova
A. I. Chernyavina
author_facet M. V. Surovtseva
N. A. Koziolova
A. I. Chernyavina
author_sort M. V. Surovtseva
collection DOAJ
description Aim. In patients with chronic heart failure (CHF) of ischemic aetiology, to assess the dynamics of heart rate variability (HRV) and ventricular ectopic activity during the complex, ivabradine-including therapy. Material and methods. In total, 90 patients with CHF and stable angina pectoris were examined. All participants were randomised into three equally sized groups: Group 1, receiving perindopril and ivabradine, as a part of the complex treatment; Group 2, receiving perindopril, bisoprolol, and ivabradine; and Group 3, receiving perindopril and bisoprolol. The therapy duration was 6 months. At baseline and in the end of the treatment phase, the following parameters were assessed: HRV measures (mean 24-hour hear rate (HR), SDNN, triangular index (HRVti), and mean weighted variation of rhythmogram (MWVR)); mean 24-hour QT, QTc, QTc dispersion (QTcd), and ventricular extrasystolia (VE). Results. The treatment was associated with a significantly greater reduction of mean 24-hour HR in Groups 1 and 2 vs. Group 3 (p<0,001). In Group 3, the SDNN increase was significantly lower than in Groups 1 and 2 (p><0,001), where SDNN values were similar (p=0,091). Group 3 also demonstrated a significantly ><0,001). In Group 3, the SDNN increase was significantly lower than in Groups 1 and 2 (p<0,001), where SDNN values were similar (p=0,091). Group 3 also demonstrated a significantly ><0,001), where SDNN values were similar (p=0,091). Group 3 also demonstrated a significantly lower increase in MWVR, compared to Groups 1 and 2 (p<0,001). This parameter was similar in Groups 1 and 2 (p=0,065). The increase in HRVti was more pronounced in Group 2 than in Groups 1 and 3 (p><0,001). The reduction in the total 24-hour VE number was significantly more pronounced in Group 2 than in Groups 1 and 3 (p><0,001). The dynamics of 24-hour QTc and QTcd was similar across three groups.><0,001). This parameter was similar in Groups 1 and 2 (p=0,065). The increase in HRVti was more pronounced in Group 2 than in Groups 1 and 3 (p<0,001). The reduction in the total 24-hour VE number was significantly more pronounced in Group 2 than in Groups 1 and 3 (p<0,001). The dynamics of 24-hour QTc and QTcd was similar across three groups. Conclusion. Including ivabradine in the complex therapy of patients with CHF and stable angina pectoris was associated with improved HRV, no marked QTc or QTcd changes, and a moderate preventive effect on VE.
first_indexed 2024-04-09T20:51:28Z
format Article
id doaj.art-db0be790fdec4bb3b578615a5562098e
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2024-04-09T20:51:28Z
publishDate 2012-12-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-db0be790fdec4bb3b578615a5562098e2023-03-29T21:23:19Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202012-12-010660651097DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILUREM. V. Surovtseva0N. A. Koziolova1A. I. Chernyavina2Academician E. A. Vagner Perm State Medical Academy, PermAcademician E. A. Vagner Perm State Medical Academy, PermAcademician E. A. Vagner Perm State Medical Academy, PermAim. In patients with chronic heart failure (CHF) of ischemic aetiology, to assess the dynamics of heart rate variability (HRV) and ventricular ectopic activity during the complex, ivabradine-including therapy. Material and methods. In total, 90 patients with CHF and stable angina pectoris were examined. All participants were randomised into three equally sized groups: Group 1, receiving perindopril and ivabradine, as a part of the complex treatment; Group 2, receiving perindopril, bisoprolol, and ivabradine; and Group 3, receiving perindopril and bisoprolol. The therapy duration was 6 months. At baseline and in the end of the treatment phase, the following parameters were assessed: HRV measures (mean 24-hour hear rate (HR), SDNN, triangular index (HRVti), and mean weighted variation of rhythmogram (MWVR)); mean 24-hour QT, QTc, QTc dispersion (QTcd), and ventricular extrasystolia (VE). Results. The treatment was associated with a significantly greater reduction of mean 24-hour HR in Groups 1 and 2 vs. Group 3 (p<0,001). In Group 3, the SDNN increase was significantly lower than in Groups 1 and 2 (p><0,001), where SDNN values were similar (p=0,091). Group 3 also demonstrated a significantly ><0,001). In Group 3, the SDNN increase was significantly lower than in Groups 1 and 2 (p<0,001), where SDNN values were similar (p=0,091). Group 3 also demonstrated a significantly ><0,001), where SDNN values were similar (p=0,091). Group 3 also demonstrated a significantly lower increase in MWVR, compared to Groups 1 and 2 (p<0,001). This parameter was similar in Groups 1 and 2 (p=0,065). The increase in HRVti was more pronounced in Group 2 than in Groups 1 and 3 (p><0,001). The reduction in the total 24-hour VE number was significantly more pronounced in Group 2 than in Groups 1 and 3 (p><0,001). The dynamics of 24-hour QTc and QTcd was similar across three groups.><0,001). This parameter was similar in Groups 1 and 2 (p=0,065). The increase in HRVti was more pronounced in Group 2 than in Groups 1 and 3 (p<0,001). The reduction in the total 24-hour VE number was significantly more pronounced in Group 2 than in Groups 1 and 3 (p<0,001). The dynamics of 24-hour QTc and QTcd was similar across three groups. Conclusion. Including ivabradine in the complex therapy of patients with CHF and stable angina pectoris was associated with improved HRV, no marked QTc or QTcd changes, and a moderate preventive effect on VE.https://russjcardiol.elpub.ru/jour/article/view/1305heart failureheart rate variabilityventricular ectopic activitycomplex treatmentivabradine
spellingShingle M. V. Surovtseva
N. A. Koziolova
A. I. Chernyavina
DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE
Российский кардиологический журнал
heart failure
heart rate variability
ventricular ectopic activity
complex treatment
ivabradine
title DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE
title_full DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE
title_fullStr DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE
title_full_unstemmed DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE
title_short DYNAMICS OF HEART RATE VARIABILITY AND VENTRICULAR ECTOPIC ACTIVITY IN IVABRADINE-TREATED PATIENTS WITH CHRONIC HEART FAILURE
title_sort dynamics of heart rate variability and ventricular ectopic activity in ivabradine treated patients with chronic heart failure
topic heart failure
heart rate variability
ventricular ectopic activity
complex treatment
ivabradine
url https://russjcardiol.elpub.ru/jour/article/view/1305
work_keys_str_mv AT mvsurovtseva dynamicsofheartratevariabilityandventricularectopicactivityinivabradinetreatedpatientswithchronicheartfailure
AT nakoziolova dynamicsofheartratevariabilityandventricularectopicactivityinivabradinetreatedpatientswithchronicheartfailure
AT aichernyavina dynamicsofheartratevariabilityandventricularectopicactivityinivabradinetreatedpatientswithchronicheartfailure